Joint research effort will lead to molecular assays that can improve variant detection and access difficult-to-sequence regions of the human genomeAUSTIN, Texas and MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and Asuragen, a molecular diagnostics company delivering easy-to-use products for complex […]

Cancer Transcriptome Atlas is the First in a Portfolio of GeoMx Products That Enable Spatial Genomics Using the Installed Base of Nearly 20,000 Next Gen Sequencers SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the first GeoMx® Digital Spatial […]

Ground-breaking British technology will initially provide hundreds of thousands of fast, accurate, low-cost COVID-19 tests under new agreement with the UK Government, with the potential to build to millions of tests per month The “LamPORE COVID-19” assay provides precise detection of SARS-CoV-2, the virus that causes COVID-19, using Oxford Nanopore’s DNA/RNA sequencing technology. LamPORE is […]

SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering, for a proposed project under the agency’s Rapid Acceleration of Diagnostics (RADx) […]

Today we launched the Long SIRV module. The long SIRVs are the latest addition to the Spike-In RNA Variants (SIRVs), Lexogen’s portfolio of external RNA reference standards. The 15 RNAs in this module cover the five length categories of 4 kb, 6 b, 8 kb, 10 kb, and 12 kb, each represented by three unique transcripts. […]

Fluidigm among First Seven Companies to Advance in Historic and Rapidly Instituted Program to Support Development and Commercialization of Innovative COVID-19 Testing Technologies SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the […]

Diagenode expands services offering by introducing new high-throughput 3’mRNA sequencing service that utilizes MERCURIUS technology Diagenode, a leading global provider of solutions for epigenetics research and sample preparation, has partnered with Alithea Genomics to provide a novel low cost, high performance 3’ mRNA-seq service to help advance transcriptomics research. The new Alithea-powered technology, known as “MERCURIUS”, enables reliable […]

Entire HTG RUO profiling assay menu now available for use on both Illumina’s and Thermo Fisher Scientific’s NGS platform TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced three of its previously released Research Use Only (RUO) assays are now available […]

University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery Akoya, UCSF and the I-SPY TRIAL consortium collaborate to discover and validate biomarker signatures for predicting response to neoadjuvant and adjuvant immunotherapies Akoya Biosciences, Inc., The Spatial Biology Company™, today announced a collaboration with UCSF Helen Diller Family Comprehensive Cancer Center. […]

Casdin Capital leads the $50M extension; funding will support commercial launch of SYNTAX™️ — the world’s first enzymatic DNA printer. PARIS and SOUTH SAN FRANCISCO, Calif.: DNA Script today announced a $50 million extension to its Series B financing, bringing the total investment of this round to $89 million. This oversubscribed round is led by […]